Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-089523
Filing Date
2025-09-19
Accepted
2025-09-19 16:02:03
Documents
2
Period of Report
2025-09-19

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0258051-6k_nlspharma.htm 6-K 13479
2 LETTER FROM MARCUM LLP ADDRESSED TO THE U.S. SECURITIES AND EXCHANGE COMMISSION ea025805101ex16-1_nlspharma.htm EX-16.1 2397
  Complete submission text file 0001213900-25-089523.txt   16977
Mailing Address THE CIRCLE 6 8058 ZURICH Switzerland
Business Address THE CIRCLE 6 8058 ZURICH Switzerland 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 251326796
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)